EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors

Clinical trial NCT07163325 · RECRUITING

Trial details

NCT number: NCT07163325
Sponsor: Epics Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor (Phase 1)

Start date: 2025-07-24
Primary completion: 2027-11-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.